These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Twice-daily dosing of Nelfinavir approved.
    Journal: Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888.
    Abstract:
    Nelfinavir (Viracept), was approved by the US Food & Drug Administration (FDA) for a lower daily dose, following a phase III trial. The new dose of 1,250 mg is taken twice a day, as opposed to the previous 750 mg of Nelfinavir taken three times a day. Diarrhea was a side effect found in less than one-fifth of patients taking either previous dosages or the new regimen.
    [Abstract] [Full Text] [Related] [New Search]